abstract |
The invention relates to novel tetrahydro-isoquinoline derivatives of formula (I), which have affinity for the 5-HT6 receptor and are useful in the treatment of various cns disorders. In said formula J is selected from a group of formula (a), (b) or (c) in which (a) is a group (i), (b) is a group (ii), (c) is a group (iii). |